Phase IA/IB Evaluation of Mammalian Cell‐derived Glycosylated Recombinant Human Interleukin (SIGOSIX) before and after Cytotoxic Chemotherapy

P. S. Ritch, C. Keever, J. Schiller, S. Rivkin, P. L. Witt, S. E. Grossberg, R. L. Truitt, H. Burris, D. D. Von Hoff, L. Vaickus, D. Drechsler, E. C. Borden, A. Galazka, J. B. Breitmeyer, A. Abdul-Ahad

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)359-360
Number of pages2
JournalAnnals of the New York Academy of Sciences
Volume762
Issue number1
DOIs
StatePublished - Jul 1995

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • History and Philosophy of Science

Cite this

Ritch, P. S., Keever, C., Schiller, J., Rivkin, S., Witt, P. L., Grossberg, S. E., Truitt, R. L., Burris, H., Von Hoff, D. D., Vaickus, L., Drechsler, D., Borden, E. C., Galazka, A., Breitmeyer, J. B., & Abdul-Ahad, A. (1995). Phase IA/IB Evaluation of Mammalian Cell‐derived Glycosylated Recombinant Human Interleukin (SIGOSIX) before and after Cytotoxic Chemotherapy. Annals of the New York Academy of Sciences, 762(1), 359-360. https://doi.org/10.1111/j.1749-6632.1995.tb32340.x